---
title: "Off-Label Use, Definition | MedTech Terms"
description: "Use of a device for an indication not in its cleared/approved labeling. Plain-English Commercialization definition for MedTech teams, with examples and related"
lang: en
json-ld: |
  {
    "@context": "https://schema.org",
    "@graph": [
      {
        "@type": "DefinedTerm",
        "@id": "https://medtechterms.com/terms/off-label-use#term",
        "name": "Off-Label Use",
        "description": "Physicians may legally use a cleared device off-label in the practice of medicine. Manufacturers may not promote off-label use; doing so risks FDA enforcement and False Claims Act exposure when federal payment is involved.",
        "url": "https://medtechterms.com/terms/off-label-use",
        "termCode": "off-label-use",
        "inDefinedTermSet": {
          "@type": "DefinedTermSet",
          "name": "MedTech Terms",
          "url": "https://medtechterms.com/terms"
        }
      },
      {
        "@type": "Article",
        "@id": "https://medtechterms.com/terms/off-label-use#article",
        "headline": "Off-Label Use",
        "description": "Use of a device for an indication not in its cleared/approved labeling.",
        "url": "https://medtechterms.com/terms/off-label-use",
        "mainEntityOfPage": {
          "@type": "WebPage",
          "@id": "https://medtechterms.com/terms/off-label-use"
        },
        "about": {
          "@id": "https://medtechterms.com/terms/off-label-use#term"
        },
        "articleSection": "Commercialization",
        "inLanguage": "en",
        "keywords": "Off-Label Use, Commercialization, medical device, MedTech",
        "author": {
          "@type": "Person",
          "name": "Christian Espinosa",
          "jobTitle": "Founder, Blue Goat Cyber",
          "url": "https://bluegoatcyber.com"
        },
        "publisher": {
          "@type": "Organization",
          "name": "MedTech Terms",
          "url": "https://medtechterms.com"
        },
        "isPartOf": {
          "@type": "WebSite",
          "name": "MedTech Terms",
          "url": "https://medtechterms.com"
        },
        "datePublished": "2026-05-05",
        "dateModified": "2026-05-05",
        "citation": [
          {
            "@type": "CreativeWork",
            "name": "AdvaMed Code of Ethics",
            "url": "https://www.advamed.org/our-work/code-of-ethics/",
            "publisher": {
              "@type": "Organization",
              "name": "AdvaMed"
            }
          },
          {
            "@type": "CreativeWork",
            "name": "AHRMM - Healthcare Supply Chain",
            "url": "https://www.ahrmm.org/",
            "publisher": {
              "@type": "Organization",
              "name": "AHRMM"
            }
          }
        ],
        "mentions": [
          {
            "@type": "DefinedTerm",
            "@id": "https://medtechterms.com/terms/label-claims#term",
            "name": "Label Claims",
            "url": "https://medtechterms.com/terms/label-claims"
          }
        ]
      },
      {
        "@type": "BreadcrumbList",
        "itemListElement": [
          {
            "@type": "ListItem",
            "position": 1,
            "name": "Home",
            "item": "https://medtechterms.com/"
          },
          {
            "@type": "ListItem",
            "position": 2,
            "name": "Terms",
            "item": "https://medtechterms.com/terms"
          },
          {
            "@type": "ListItem",
            "position": 3,
            "name": "Commercialization",
            "item": "https://medtechterms.com/terms?cat=Commercialization"
          },
          {
            "@type": "ListItem",
            "position": 4,
            "name": "Off-Label Use",
            "item": "https://medtechterms.com/terms/off-label-use"
          }
        ]
      },
      {
        "@type": "FAQPage",
        "@id": "https://medtechterms.com/terms/off-label-use#faq",
        "mainEntity": [
          {
            "@type": "Question",
            "name": "Can a manufacturer provide information about off-label uses if asked by a healthcare professional?",
            "acceptedAnswer": {
              "@type": "Answer",
              "text": "Yes, manufacturers can generally respond to unsolicited requests for information about off-label uses from healthcare professionals, provided the information is truthful, balanced, evidence-based, and non-promotional. This is often covered under specific FDA guidance for unsolicited requests."
            }
          },
          {
            "@type": "Question",
            "name": "What kind of information can manufacturers share about off-label uses?",
            "acceptedAnswer": {
              "@type": "Answer",
              "text": "Manufacturers may share scientific or medical information that is consistent with FDA guidance, such as peer-reviewed journal articles, medical texts, or scientific presentations, in response to unsolicited requests. The communication must be factual and non-promotional in nature."
            }
          },
          {
            "@type": "Question",
            "name": "Are there any situations where off-label use by a physician is discouraged by regulators?",
            "acceptedAnswer": {
              "@type": "Answer",
              "text": "While generally permissible, regulators may raise concerns if an off-label use becomes a widespread practice without adequate scientific evidence, particularly if it poses significant patient safety risks. The physician's responsibility is paramount in such situations."
            }
          }
        ]
      }
    ]
  }
---

[

MedTech Terms

The authoritative reference



](/)

Browse

Learn

[Latest](/latest)

About

1.  [Home](/)
2.  /
3.  [Terms](/terms)
4.  /
5.  [Commercialization](/terms?cat=Commercialization)
6.  /
7.  Off-Label Use

[All terms](/terms)

Commercialization [Hospital Buyer & Reimbursement](/ecosystems/hospital-buyer)

# Off-Label Use

Use of a device for an indication not in its cleared/approved labeling.

Reviewed by [Christian Espinosa, Founder, Blue Goat Cyber](/authors/christian-espinosa) Last reviewed May 5, 2026 

## Definition

Physicians may legally use a cleared device off-label in the practice of medicine. Manufacturers may not promote off-label use; doing so risks FDA enforcement and False Claims Act exposure when federal payment is involved. 

What the regulation says

The FDA recognizes that off-label use is often an important part of medical practice, as outlined in FDA guidance documents on unapproved uses of approved drugs and medical devices. However, manufacturers are strictly prohibited from promoting off-label uses of their MedTech products, a principle reinforced by Section 502(a) of the Food, Drug, and Cosmetic Act concerning misbranding. The European Medical Device Regulation (EU  [MDR](/terms/mdr-reporting)) also implicitly addresses off-label use by requiring devices to be  [safe](/terms/safe-note) and perform as intended by the manufacturer within their "intended purpose," as defined in Article 2, point 12. 

## What this means in practice

Common in cardiology, orthopedics, and pediatrics where on-label populations are narrow. Manufacturers may share scientific information consistent with FDA guidance on responsive communications. 

## Examples

-   A surgeon uses an FDA-cleared surgical stapler, approved for abdominal procedures, in a novel cardiothoracic application based on their clinical judgment and peer-reviewed literature.
-   A medical device company provides a healthcare professional with a reprint of a peer-reviewed article discussing a potential off-label use of their device, in response to an unsolicited request for information.
-   A physician prescribes a drug-eluting stent, approved for coronary arteries, for use in peripheral artery disease, citing scientific evidence from a professional medical society guideline.

Common pitfalls

-   • Manufacturers can be penalized under the False Claims Act if off-label promotion leads to federal healthcare program reimbursement for non-covered uses. 
-   • Assuming that the absence of a specific contraindication implies regulatory approval for an off-label application is a common pitfall. 
-   • Failing to establish clear internal policies and training regarding permissible and impermissible communications about off-label use can lead to compliance breaches. 
-   • Ignoring the ethical implications and potential patient harm associated with off-label use without sufficient scientific evidence can lead to serious consequences. 
-   • Misinterpreting FDA guidance on firm-sponsored scientific and medical exchanges regarding unapproved uses can inadvertently lead to promotional activities. 

## Frequently asked questions

Can a manufacturer provide information about off-label uses if asked by a healthcare professional? 

Yes, manufacturers can generally respond to unsolicited requests for information about off-label uses from healthcare professionals, provided the information is truthful, balanced, evidence-based, and non-promotional. This is often covered under specific FDA guidance for unsolicited requests. 

What kind of information can manufacturers share about off-label uses? 

Are there any situations where off-label use by a physician is discouraged by regulators? 

## Related terms

Grouped by theme 

### Editor's picks

· Hand-selected related concepts 

[

Commercialization

Label Claims

Indications, performance, and other statements approved or cleared for labeling.





](/terms/label-claims)

### More in Commercialization

· Same category 

[

Commercialization

AdvaMed Code of Ethics

Industry code governing interactions between U.S. medical-device companies and healthcare professionals.





](/terms/advamed-code)[

Commercialization

Advisory Board

Convening of external experts to advise on strategy or product.





](/terms/advisory-board)[

Commercialization

Anti-Kickback Statute(AKS) 

U.S. criminal statute prohibiting remuneration to induce federal healthcare business.





](/terms/anti-kickback)[

Commercialization

Bottom-Up Market Sizing

Building market size from procedure volumes × price × penetration.





](/terms/bottom-up-sizing)

Cited by

Where this term appears across MedTech Terms.

Ecosystems (1)

-   [Hospital Buyer & Reimbursement](/ecosystems/hospital-buyer)

## Mentioned in recent activity

1 entry 

PubMed (1)

[Ethical Responsibility in the Off-Label Use of AI in Medical Imaging. ](https://pubmed.ncbi.nlm.nih.gov/42127793/)

The Journal of clinical ethics · 2026-01-01 

## Latest in MedTech

[View all](/latest?term=off-label-use)

Recent regulatory actions, publications, and trials matched to this term. Updated daily.

-   PubMed 2026-01-01 
    
    [Ethical Responsibility in the Off-Label Use of AI in Medical Imaging. ](https://pubmed.ncbi.nlm.nih.gov/42127793/)
    
    The Journal of clinical ethics
    

## Primary references

2 sources 

Link health:  2 verified · last checked 2026-06-20 

AdvaMed· 1 AHRMM· 1 

1.  [1 
    
    AdvaMed Code of Ethics
    
    Verified 
    
    AdvaMed · advamed.org 
    
    
    
    ](https://www.advamed.org/our-work/code-of-ethics/)
2.  [2 
    
    AHRMM - Healthcare Supply Chain
    
    Verified 
    
    AHRMM · ahrmm.org 
    
    
    
    ](https://www.ahrmm.org/)

Inline markers like \[1\]  jump to the matching reference above.

Sponsor note

### Selling a connected device into health systems?

Hospital procurement increasingly requires MDS2, SBOM, and security questionnaires - we help your team answer them confidently.

[Book a 30-minute discovery session](https://go.bluegoatcyber.com/meetings/blue-goat-cyber/discovery-session)

-   No obligation
-   Expert-led from minute one
-   NDA available on request

MedTech Terms is a community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com). Definitions are independent of any vendor.

On this term

Category

Commercialization

Sources

2

Updated

5/5/2026

[Compare with another term](/compare?a=off-label-use)

Learn in 60 seconds

Card Lesson Quiz

Use of a device for an indication not in its cleared/approved labeling.

-   · Common in cardiology, orthopedics, and pediatrics where on-label populations are narrow. 
-   · Manufacturers may share scientific information consistent with FDA guidance on responsive communications. 
-   · Manufacturers may not promote off-label use; doing so risks FDA enforcement and False Claims Act exposure when federal payment is involved. 

Remember this

Watch out: Manufacturers can be penalized under the False Claims Act if off-label promotion leads to federal healthcare program reimbursement for non-covered uses.

Related terms

-   [Label Claims ](/terms/label-claims)

You may also need

Auto-suggested from Commercialization and shared keywords.

-   [Emergency Use Authorization(EUA) ](/terms/eua)
-   [Key Opinion Leader(KOL) ](/terms/kol)
-   [Physician Payments Sunshine Act ](/terms/sunshine-act)
-   [Stark Law ](/terms/stark-law)
-   [Medicare Physician Fee Schedule(MPFS) ](/terms/physician-fee-schedule)
-   [AdvaMed Code of Ethics ](/terms/advamed-code)

[All Commercialization terms](/terms?cat=Commercialization)

MedTech Terms 

An authoritative, plain-language reference for the regulatory, quality, cybersecurity, and software terms that shape modern medical devices.

Browse

-   [All terms](/terms)
-   [A–Z index](/a-z)
-   [Categories](/categories)
-   [Ecosystems](/ecosystems)
-   [Learning paths](/paths)
-   [Compare terms](/compare)
-   [Quiz](/quiz)

Resources

-   [FDA Medical Devices](https://www.fda.gov/medical-devices)
-   [EU MDR](https://eur-lex.europa.eu/eli/reg/2017/745/oj)
-   [IMDRF](https://www.imdrf.org/)
-   [Methodology](/methodology)
-   [Changelog](/changelog)
-   [Editor: Christian Espinosa](/authors/christian-espinosa)
-   [About this site](/about)

© 2026 MedTech Terms. Reference content for educational purposes - not regulatory advice. A community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com)